Genex Power

James Rogalsky Joins ATF Medical as Vice President, Client Services

Retrieved on: 
Monday, October 9, 2023
Insurance, Managed Care, Medical Supplies, Finance, Health, Medical Devices, Professional Services, Health Insurance, Multimedia, PCS, ATF, Genex Power, Patient, Management, Nursing, Apricus Biosciences

ATF Medical has expanded its leadership team with the addition of James J. Rogalsky as vice president of client services, a newly created position.

Key Points: 
  • ATF Medical has expanded its leadership team with the addition of James J. Rogalsky as vice president of client services, a newly created position.
  • View the full release here: https://www.businesswire.com/news/home/20231009700966/en/
    James Rogalsky joins ATF Medical as Vice President, Client Services.
  • (Photo: Business Wire)
    Most recently Rogalsky served as vice president of client services for PhysNet, a Jacksonville, Florida-based physical therapy workers’ comp network.
  • My previous companies used ATF Medical’s services and it’s fun to be on the other side of the coin,” Rogalsky said.

Enlyte Announces Winners of 2023 Heart of Case Management Awards

Retrieved on: 
Wednesday, October 11, 2023
Shortage, Pain, Male, IVC, Falling, Family, Burn, Paralysis, Knee, Thrombosis, Pulmonary artery, Chest pain, PBM, Embolism, Risk, Cardiology, Communication, Injury, T-11, Concussion, Neurology, Electricity, Arm, Trust, Motivation, Education, Hypertrophic scar, CT, SVP, Artery, SAN, Head, ICU, Case management, Shoulder, Burns, Hematology, Tracheotomy, Medical case management, Quality of life, Nursing, Health insurance, Genex Power

SAN DIEGO, Oct. 11, 2023 /PRNewswire/ -- Enlyte, a leader in cost-containment technology, provider networks, clinical services, pharmacy benefit management (PBM) and disability management, has announced the winners of the 2023 Heart of Case Management Awards, a prestigious honor recognizing four individuals nominated by their managers and selected from a field of more than 2,000 case managers across the country.

Key Points: 
  • SAN DIEGO, Oct. 11, 2023 /PRNewswire/ -- Enlyte, a leader in cost-containment technology, provider networks, clinical services, pharmacy benefit management (PBM) and disability management, has announced the winners of the 2023 Heart of Case Management Awards, a prestigious honor recognizing four individuals nominated by their managers and selected from a field of more than 2,000 case managers across the country.
  • This was the case for this year's winners of Genex's Heart of Case Management Awards, who overcame overwhelming odds to help injured employees meet their recovery goals.
  • Among this year's winners is a case manager who used her critical thinking skills to allow an Amish builder to return to function following a spinal cord injury.
  • Nominees are judged on a multitude of criteria including expertise, excellence, adaptability, trust, influential communication, critical thinking and outcomes.

Avalon GloboCare’s Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States

Retrieved on: 
Wednesday, July 19, 2023
Aetna, CAP, COVID-19, Genex Power, Genetic testing, Cigna, National Health Laboratory Service, Medicare, LSM, MSA, Laboratory, Master service agreement, Others, LC-MS, Instrumental chemistry, MSO, UnitedHealth Group, Toxicology testing, Pharmaceutical industry, Medicaid

FREEHOLD, N.J., July 19, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced Laboratory Services MSO, LLC (“LSM”), has signed an exclusive Master Service Agreement (“MSA”) with GeneX Laboratory Professional Corp. (“GeneX”). Avalon owns a 40% interest in LSM.

Key Points: 
  • Genex is a CLIA-certified and CAP-accredited laboratory located in Orange County, California that has been dormant and seeking a partner to utilize their valuable license networks.
  • Those tests will now be performed utilizing the LSM infrastructure and resources providing significant expansion opportunity for LSM to perform services through in-network insurance providers previously unavailable.
  • GeneX provides top-tier, comprehensive laboratory testing services and works with major providers in addition to Medicaid in 21 states.
  • By leveraging LSM’s experience and infrastructure, we expect to achieve significant synergies with respect to revenue growth and market shares,” concluded Dr. Jin.

STIMULAN now available in South Africa to treat bacterial infection

Retrieved on: 
Wednesday, May 10, 2023
Infection, Surgeon, University, Freedom, University of Cape Town, Genex Power, Doctor of Philosophy, Associate, Hospital, Vancomycin, Patient, Division, Neoplasm, Orthopedic surgery, Genetically modified bacteria, Tobramycin, Stellenbosch University, Pharmaceutical industry, EU, Sepsis

KEELE, England, May 10, 2023 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces that its STIMULAN® products are now available in South Africa for treating bacterial infection.

Key Points: 
  • KEELE, England, May 10, 2023 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces that its STIMULAN® products are now available in South Africa for treating bacterial infection.
  • South Africa now joins a growing list of countries, which include the UK, EU, Canada, Mexico and Saudi Arabia where STIMULAN can carry antibiotics, such as vancomycin, gentamicin and tobramycin to a site of infection.
  • STIMULAN is the first and only approved calcium matrix that can carry antibiotics to treat bacterial infection and is now used in over 80,000 procedures every year, in thousands of hospitals around the world.
  • Nando Fereira, PhD, Full Professor and Head of Clinical Unit (Tumour, Sepsis, and Reconstruction) at Stellenbosch University added: "I am excited to learn that STIMULAN will soon be available in South Africa through Novus Healthcare.

STIMULAN now available in South Africa to treat bacterial infection

Retrieved on: 
Wednesday, May 10, 2023
Infection, Surgeon, University, Freedom, University of Cape Town, Genex Power, Doctor of Philosophy, Associate, Hospital, Vancomycin, Patient, Division, Neoplasm, Orthopedic surgery, Genetically modified bacteria, Tobramycin, Stellenbosch University, Pharmaceutical industry, EU, Sepsis

KEELE, England, May 10, 2023 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces that its STIMULAN® products are now available in South Africa for treating bacterial infection.

Key Points: 
  • KEELE, England, May 10, 2023 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces that its STIMULAN® products are now available in South Africa for treating bacterial infection.
  • South Africa now joins a growing list of countries, which include the UK, EU, Canada, Mexico and Saudi Arabia where STIMULAN can carry antibiotics, such as vancomycin, gentamicin and tobramycin to a site of infection.
  • STIMULAN is the first and only approved calcium matrix that can carry antibiotics to treat bacterial infection and is now used in over 80,000 procedures every year, in thousands of hospitals around the world.
  • Nando Fereira, PhD, Full Professor and Head of Clinical Unit (Tumour, Sepsis, and Reconstruction) at Stellenbosch University added: "I am excited to learn that STIMULAN will soon be available in South Africa through Novus Healthcare.

Enlyte Honored with Two 2023 American Business Awards®

Retrieved on: 
Monday, May 1, 2023
Workforce, Bronze, Stevie Awards, Abas, Marriott Marquis, Organization, Gold, American Business Women's Association, SAN, Mitchell, Genex Power

SAN DIEGO, May 1, 2023 /PRNewswire/ -- Enlyte has been recognized by the American Business Association with two prestigious awards for its achievements in merging three leading companies into one brand as well as its efforts in developing an industry trends report.

Key Points: 
  • SAN DIEGO, May 1, 2023 /PRNewswire/ -- Enlyte has been recognized by the American Business Association with two prestigious awards for its achievements in merging three leading companies into one brand as well as its efforts in developing an industry trends report.
  • Enlyte won a Gold Stevie® Award for Best E-Book and a Bronze Stevie® Award for Achievement in Management as part of the 21st Annual American Business Awards® (ABAs).
  • The ABAs are the country's premier business awards program.
  • We're honored to have these achievements and hard work recognized by the American Business Awards."

Cure® Launches New Event Series, CureX, on Rare Disease Day with Keynote Speaker and Entrepreneurial Trailblazer, Jamie Heywood

Retrieved on: 
Wednesday, February 22, 2023
Cure, PatientsLikeMe, Disease, GeneDx, EST, Park Avenue, Genex Power, ALS Therapy Development Institute, Rare Disease Day, Science, Women's health, 345 Park Avenue, Health, Rare disease, ALS, Pharmaceutical industry

In honor of Rare Disease Day, Tuesday's CureX event will discuss the current state of affairs for the 30 million Americans afflicted with a rare disease, about 1 in 10 people.

Key Points: 
  • In honor of Rare Disease Day, Tuesday's CureX event will discuss the current state of affairs for the 30 million Americans afflicted with a rare disease, about 1 in 10 people.
  • Keynote speaker Jamie Heywood, Founder of PatientsLikeMe and the ALS Therapy Development Institute, along with panel experts including scientist Paul Kruzka and CEO Mette Dyhrberg, will share their stories in the journey for cures.
  • The event will take place on the iconic rooftop of Cure at 345 Park Avenue South on Tuesday, February 28, beginning at 5:30 p.m. EST.
  • Stay connected with us on LinkedIn for future CureX events, including our upcoming March events focused on Women's Health.

Biocomposites announces year of record sales and company growth

Retrieved on: 
Wednesday, December 14, 2022
Genex Power, Genetically modified bacteria, Queen's Award, Ankle, International trade, Conference, Queen's Awards for Enterprise, Wound healing, Infection, Spine, Partnership, Podiatry, Enterprise, Diabetic foot, NYSE, Surgeon, Trauma, HM, Growth, Foot, Pharmaceutical industry, EU

KEELE, England, Dec. 14, 2022 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is celebrating its 25th anniversary in a year that has seen the company deliver its highest year-on-year sales growth and receive two prestigious Queen's Awards for Enterprise.

Key Points: 
  • In Germany, the company invested in a new Sales Manager for Northern Europe to take the benefit of STIMULAN to new surgeons in new geographies.
  • Commenting on Biocomposites' outstanding progress this year, Michael Harris, Chief Executive Officer, said: "2022 has been a standout year for the company.
  • Biocomposites is an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue.
  • Biocomposites products are now used in over 120,000 procedures per annum and sold in more than 40 countries around the world.

Biocomposites announces year of record sales and company growth

Retrieved on: 
Wednesday, December 14, 2022
Genex Power, Genetically modified bacteria, Queen's Award, Ankle, International trade, Conference, Queen's Awards for Enterprise, Wound healing, Infection, Spine, Partnership, Podiatry, Enterprise, Diabetic foot, NYSE, Surgeon, Trauma, HM, Growth, Foot, Pharmaceutical industry, EU

KEELE, England, Dec. 14, 2022 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is celebrating its 25th anniversary in a year that has seen the company deliver its highest year-on-year sales growth and receive two prestigious Queen's Awards for Enterprise.

Key Points: 
  • In Germany, the company invested in a new Sales Manager for Northern Europe to take the benefit of STIMULAN to new surgeons in new geographies.
  • Commenting on Biocomposites' outstanding progress this year, Michael Harris, Chief Executive Officer, said: "2022 has been a standout year for the company.
  • Biocomposites is an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue.
  • Biocomposites products are now used in over 120,000 procedures per annum and sold in more than 40 countries around the world.

Mitchell Selected as the Preferred North American Technology Provider of Vale's Paintless Dent Repair (PDR) Technician Certification Program

Retrieved on: 
Thursday, December 8, 2022
Cloud, Collision, Ecosystem, PDR, P&C, DTC, Disability, Property & Casualty Management Systems, Service King Collision Repair, Pharmacy, Mitchell, Calibration, Property, Original equipment manufacturer, Artificial intelligence, Growth, Multimedia, OEM, Bosch, Genex Power, SAN, Mitchell International, Paint, Insurance, Mobile phone, Risk management

SAN DIEGO, Dec. 8, 2022 /PRNewswire/ -- Mitchell, an Enlyte company and leading technology and information provider for the Property & Casualty (P&C) claims and Collision Repair industries, today announced that Dented Paintless Repairs, Inc. named it the preferred technology provider of the Vale PDR Technician Certification Program in Canada. This designation—combined with Mitchell's 2021 selection as U.S. PDR technology provider of the Vale program now administered by HM Verified, LLC-—demonstrates the company's continued growth in this segment. It also gives more than 30,000 PDR professionals access to Mitchell's advanced technologies as they repair today's complex vehicles.

Key Points: 
  • The Vale PDR certification program requires technicians to demonstrate that they excel in the highly specialized process of paintless dent repair.
  • Unlike traditional repair methods, PDR removes damage to exterior components without using paint or body filler, providing a highly eco-friendly repair.
  • "Mitchell continues to invest in, and prioritize, proper and safe repair," said Jack Rozint, senior vice president of repair sales at Mitchell.
  • Mitchell is also technology provider of the U.S. Vale-certified PDR technician program and, in 2022, received the same designation from HM Dent Works Academy , a comprehensive paintless dent repair training school.